• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氙预处理在体内对p44/42丝裂原活化蛋白激酶(细胞外信号调节激酶1/2)和p46/54丝裂原活化蛋白激酶(应激活化蛋白激酶1/2和3)有不同的调节作用。

Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo.

作者信息

Weber N C, Stursberg J, Wirthle N M, Toma O, Schlack W, Preckel B

机构信息

Department of Anaesthesiology, University Hospital of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.

出版信息

Br J Anaesth. 2006 Sep;97(3):298-306. doi: 10.1093/bja/ael153. Epub 2006 Jun 21.

DOI:10.1093/bja/ael153
PMID:16793779
Abstract

BACKGROUND

Xenon (Xe) induces preconditioning (PC) of the rat heart in vivo via activation of p38 mitogen-activated protein kinase (MAPK). The role of ERK 1/2 and JNK 1/2 and 3 in Xe-PC has yet not been determined.

METHODS

For infarct size measurements, anaesthetized rats were subjected to 25 min of coronary artery occlusion followed by 120 min of reperfusion. Animals received Xe 70% during three 5 min periods with and without the ERK inhibitor PD 98059 (1 mg kg(-1), PD) or the JNK inhibitor SP 600125 (6 mg kg(-1), SP) (n=10 per group). Additional hearts were excised for western blot and kinase activity assay: without further treatment, after the first, the second and the third period of Xe-PC or at the end of the last washout phase (n=4 each).

RESULTS

Infarct size (% of area at risk) was reduced from 46.2 (8.1)% to 28.4 (11.3)% after Xe-PC (P<0.01). PD completely abolished this effect [49.7 (11.4)%, P<0.01 vs Xe-PC]. The ratio of particulate/cytosolic phospho ERK 1/2 was time dependently increased during the PC protocol [ERK 1: 15 min: 2.4 (1.2), 25 min: 1.5 (0.3), 35 min: 1.6 (0.7), 45 min: 1.5 (0.5) vs Con 1.0 (0.5) and ERK 2: 15 min: 3.3 (1.8), 25 min: 2.0 (1.5), 35 min: 1.8 (1.7), 45 min: 0.9 (0.6) vs Con 0.8 (0.4)]. This finding was confirmed by a non-radioactive MAPK activity assay. In contrast SP had no effect on Xe-PC and the phosphorylation state of JNK was not influenced by Xe-PC.

CONCLUSION

Besides the p38 MAPK, ERK 1/2 also is a mediator of Xe-PC. However, JNK is not involved, demonstrating a highly specific regulation of different kinases during Xe-PC.

摘要

背景

氙气(Xe)通过激活p38丝裂原活化蛋白激酶(MAPK)在体内诱导大鼠心脏产生预处理(PC)。然而,细胞外信号调节激酶1/2(ERK 1/2)以及c-Jun氨基末端激酶1/2和3(JNK 1/2和3)在Xe-PC中的作用尚未明确。

方法

为测量梗死面积,将麻醉后的大鼠进行25分钟冠状动脉闭塞,随后再灌注120分钟。在有或没有ERK抑制剂PD 98059(1 mg·kg⁻¹,PD)或JNK抑制剂SP 600125(6 mg·kg⁻¹,SP)的情况下,动物在三个5分钟时间段内吸入70%的Xe(每组n = 10)。另外切除心脏用于蛋白质免疫印迹和激酶活性测定:未进行进一步处理、在Xe-PC的第一个、第二个和第三个时间段后或在最后洗脱阶段结束时(每组n = 4)。

结果

Xe-PC后梗死面积(危险区域面积的百分比)从46.2(8.1)%降至28.4(11.3)%(P < 0.01)。PD完全消除了这种作用[49.7(11.4)%,与Xe-PC相比P < 0.01]。在PC方案期间,颗粒状/胞质磷酸化ERK 1/2的比例呈时间依赖性增加[ERK 1:15分钟:2.4(1.2),25分钟:1.5(0.3),35分钟:1.6(0.7),45分钟:1.5(0.5),而对照组为1.0(0.5);ERK 2:15分钟:3.3(1.8),25分钟:2.0(1.5),35分钟:1.8(1.7),45分钟:0.9(0.6),而对照组为0.8(0.4)]。这一发现通过非放射性MAPK活性测定得到证实。相比之下,SP对Xe-PC没有影响,且Xe-PC不影响JNK的磷酸化状态。

结论

除p38 MAPK外,ERK 1/2也是Xe-PC的介质。然而,JNK不参与其中,这表明在Xe-PC过程中不同激酶存在高度特异性的调节。

相似文献

1
Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo.氙预处理在体内对p44/42丝裂原活化蛋白激酶(细胞外信号调节激酶1/2)和p46/54丝裂原活化蛋白激酶(应激活化蛋白激酶1/2和3)有不同的调节作用。
Br J Anaesth. 2006 Sep;97(3):298-306. doi: 10.1093/bja/ael153. Epub 2006 Jun 21.
2
Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway.氙气和异氟烷诱导的预处理机制——通过丝裂原活化蛋白激酶激活蛋白激酶-2/热休克蛋白27途径与细胞骨架的潜在联系
Br J Pharmacol. 2005 Oct;146(3):445-55. doi: 10.1038/sj.bjp.0706324.
3
The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.惰性气体氙通过诱导蛋白激酶C-ε(PKC-ε)和p38丝裂原活化蛋白激酶(p38 MAPK)在大鼠心脏体内诱导药理学预处理。
Br J Pharmacol. 2005 Jan;144(1):123-32. doi: 10.1038/sj.bjp.0706063.
4
Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?氙气在体内诱导晚期心脏预处理:环氧化酶2的作用?
Anesth Analg. 2008 Dec;107(6):1807-13. doi: 10.1213/ane.Ob013e31818874bf.
5
Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases.高血糖心肌中麻醉诱导预处理的阻断:不同丝裂原活化蛋白激酶的调节
Eur J Pharmacol. 2008 Sep 11;592(1-3):48-54. doi: 10.1016/j.ejphar.2008.07.010. Epub 2008 Jul 11.
6
Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.缺血预处理和β-肾上腺素能预处理对心肌细胞凋亡的抑制作用依赖于p38丝裂原活化蛋白激酶。
Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25. doi: 10.1007/s10557-006-6257-7.
7
Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.硫化氢对离体灌注大鼠心脏缺血再灌注损伤及缺血预处理的影响。
Eur J Cardiothorac Surg. 2008 Aug;34(2):344-9. doi: 10.1016/j.ejcts.2008.03.017. Epub 2008 May 5.
8
Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.氙气诱导的药理学预处理中蛋白激酶C-ε的上游信号传导。线粒体三磷酸腺苷依赖性钾通道和磷脂酰肌醇依赖性激酶-1的作用。
Eur J Pharmacol. 2006 Jun 6;539(1-2):1-9. doi: 10.1016/j.ejphar.2006.03.054. Epub 2006 May 23.
9
Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo.地氟醚预处理可在体内诱导大鼠心脏中蛋白激酶Cε以及细胞外信号调节激酶1和2的时间依赖性激活。
Anesthesiology. 2004 Dec;101(6):1372-80. doi: 10.1097/00000542-200412000-00018.
10
Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.远程与缺血预处理:丝裂原活化蛋白激酶通路的不同作用
Cardiovasc Res. 2008 Apr 1;78(1):108-15. doi: 10.1093/cvr/cvm114. Epub 2007 Dec 20.

引用本文的文献

1
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders.氙气作为阿片类物质使用障碍、酒精使用障碍及相关障碍的一种潜在治疗方法。
Med Gas Res. 2025 Jun 1;15(2):234-253. doi: 10.4103/mgr.MEDGASRES-D-24-00063. Epub 2025 Jan 13.
2
Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies.气体递质和心脏保护中的稀有气体:为未来的治疗策略揭示分子途径。
Basic Res Cardiol. 2024 Aug;119(4):509-544. doi: 10.1007/s00395-024-01061-1. Epub 2024 Jun 15.
3
Pharmacological Cardioprotection against Ischemia Reperfusion Injury-The Search for a Clinical Effective Therapy.
药理学防治缺血再灌注损伤——寻找一种临床有效的治疗方法。
Cells. 2023 May 20;12(10):1432. doi: 10.3390/cells12101432.
4
Noble gas and neuroprotection: From bench to bedside.惰性气体与神经保护:从实验台到病床边
Front Pharmacol. 2022 Nov 29;13:1028688. doi: 10.3389/fphar.2022.1028688. eCollection 2022.
5
Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?惰性气体疗法在心血管疾病中的应用:新星疗法?
Front Cardiovasc Med. 2022 Mar 16;9:802783. doi: 10.3389/fcvm.2022.802783. eCollection 2022.
6
Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest-A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial.吸入氙气对院外心脏骤停昏迷幸存者心脏功能的影响——心脏骤停试验后氙气联合低温治疗的一项子研究
Crit Care Explor. 2021 Jul 29;3(8):e0502. doi: 10.1097/CCE.0000000000000502. eCollection 2021 Aug.
7
Update of the organoprotective properties of xenon and argon: from bench to beside.氙气和氩气的器官保护特性更新:从实验室到临床应用
Intensive Care Med Exp. 2020 Feb 24;8(1):11. doi: 10.1186/s40635-020-0294-6.
8
Plasma from Volunteers Breathing Helium Reduces Hypoxia-Induced Cell Damage in Human Endothelial Cells-Mechanisms of Remote Protection Against Hypoxia by Helium.志愿者吸入氦气的血浆可减轻人内皮细胞缺氧诱导的损伤——氦气对缺氧的远程保护机制。
Cardiovasc Drugs Ther. 2019 Jun;33(3):297-306. doi: 10.1007/s10557-019-06880-2.
9
Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study.氙气麻醉下行部分肾切除术后的肾功能——一项随机对照研究的探索性分析
PLoS One. 2017 Jul 18;12(7):e0181022. doi: 10.1371/journal.pone.0181022. eCollection 2017.
10
The Molecular Pathway of Argon-Mediated Neuroprotection.氩气介导神经保护的分子途径
Int J Mol Sci. 2016 Oct 31;17(11):1816. doi: 10.3390/ijms17111816.